For patients managing viral infections, this generic medicine inhibits the reverse transcriptase enzyme. Disrupts viral replication to address underlying infection markers and systemic load.
Information related to Baraclude is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.